These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 17456779)
1. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Zen Y; Fujii T; Yoshikawa S; Takamura H; Tani T; Ohta T; Nakanuma Y Am J Pathol; 2007 May; 170(5):1750-62. PubMed ID: 17456779 [TBL] [Abstract][Full Text] [Related]
2. Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling. Hu C; Li H; Li J; Zhu Z; Yin S; Hao X; Yao M; Zheng S; Gu J Carcinogenesis; 2008 Dec; 29(12):2289-97. PubMed ID: 18820285 [TBL] [Abstract][Full Text] [Related]
3. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells. Jia Q; Zhang X; Deng T; Gao J Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193 [TBL] [Abstract][Full Text] [Related]
4. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Patrawala L; Calhoun T; Schneider-Broussard R; Zhou J; Claypool K; Tang DG Cancer Res; 2005 Jul; 65(14):6207-19. PubMed ID: 16024622 [TBL] [Abstract][Full Text] [Related]
5. Stimulus-induced expression of the ABCG2 multidrug transporter in HepG2 hepatocarcinoma model cells involves the ERK1/2 cascade and alternative promoters. de Boussac H; Orbán TI; Várady G; Tihanyi B; Bacquet C; Brózik A; Váradi A; Sarkadi B; Arányi T Biochem Biophys Res Commun; 2012 Sep; 426(2):172-6. PubMed ID: 22922104 [TBL] [Abstract][Full Text] [Related]
6. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study. Fujii T; Zen Y; Harada K; Niwa H; Masuda S; Kaizaki Y; Watanabe K; Kawashima A; Nakanuma Y Hum Pathol; 2008 Aug; 39(8):1185-96. PubMed ID: 18547618 [TBL] [Abstract][Full Text] [Related]
7. ABCG2 is a potential marker of tumor-initiating cells in breast cancer. Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795 [TBL] [Abstract][Full Text] [Related]
8. Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma. Hou H; Sun H; Lu P; Ge C; Zhang L; Li H; Zhao F; Tian H; Zhang L; Chen T; Yao M; Li J Mol Cancer Ther; 2013 Dec; 12(12):2874-84. PubMed ID: 24130050 [TBL] [Abstract][Full Text] [Related]
9. Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. Sukowati CH; Rosso N; Pascut D; Anfuso B; Torre G; Francalanci P; Crocè LS; Tiribelli C BMC Gastroenterol; 2012 Nov; 12():160. PubMed ID: 23153066 [TBL] [Abstract][Full Text] [Related]
10. The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart. Meissner K; Heydrich B; Jedlitschky G; Meyer Zu Schwabedissen H; Mosyagin I; Dazert P; Eckel L; Vogelgesang S; Warzok RW; Böhm M; Lehmann C; Wendt M; Cascorbi I; Kroemer HK J Histochem Cytochem; 2006 Feb; 54(2):215-21. PubMed ID: 16116030 [TBL] [Abstract][Full Text] [Related]
12. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition. Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100 [TBL] [Abstract][Full Text] [Related]
13. Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Christgen M; Ballmaier M; Bruchhardt H; von Wasielewski R; Kreipe H; Lehmann U Mol Cell Biochem; 2007 Dec; 306(1-2):201-12. PubMed ID: 17660947 [TBL] [Abstract][Full Text] [Related]
14. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977 [TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs. Sukowati CH; Anfuso B; Pascut D; Tiribelli C Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):723-5. PubMed ID: 25920931 [TBL] [Abstract][Full Text] [Related]
16. [Hepatocellular Carcinoma Cells with Downregulated ZEB2 Become Resistant to Resveratrol by Concomitant Induction of ABCG2 Expression]. Balcik-Ercin P; Cetin M; Yalim-Camci I; Uygur T; Yagci T Mol Biol (Mosk); 2020; 54(1):87-94. PubMed ID: 32163392 [TBL] [Abstract][Full Text] [Related]
17. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis. Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631 [TBL] [Abstract][Full Text] [Related]
18. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471 [TBL] [Abstract][Full Text] [Related]
19. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200 [TBL] [Abstract][Full Text] [Related]
20. ABCG2 expression is correlated neither to side population nor to hematopoietic progenitor function in human umbilical cord blood. Alt R; Wilhelm F; Pelz-Ackermann O; Egger D; Niederwieser D; Cross M Exp Hematol; 2009 Feb; 37(2):294-301. PubMed ID: 19101070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]